Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. DHR
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
DHR
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

DHR Price Prediction Next Week

Technical Analysis: Based on the technical indicators, DHR is showing mixed signals. The RSI(14) at 63.44 indicates the stock is approaching overbought territory but not yet overextended. The MACD at 2.53 suggests positive momentum. The stock is currently trading below its 200-day SMA of $253.30, indicating a longer-term bearish trend, but above its 20-day SMA of $237.15, showing short-term strength.

News Analysis: Recent news indicates several significant developments:

  • DHR will report Q4 earnings on January 30, 2025
  • Bank of America maintains a "Buy" rating with a $290 price target, implying an 18% upside potential
  • Wall Street analysts are overwhelmingly bullish on DHR, with most assigning either "Strong Buy" or "Buy" ratings

Price Prediction for Next Week: Based on Fibonacci levels:

  • Resistance levels: R1: $246.13, R2: $249.78, R3: $255.70
  • Support levels: S1: $234.29, S2: $230.64, S3: $224.73
  • Pivot: $240.21

Given the upcoming earnings report and current technical setup, DHR is likely to trade between $240-$250 next week. The stock should find strong support at $234.29 and face resistance at $246.13.

Trading Recommendation: BUY Rationale:

  1. Positive momentum indicators
  2. Strong analyst support with consensus bullish ratings
  3. Upcoming earnings catalyst
  4. Trading above short-term moving averages

Entry point: Current market price with stop loss at $234.29 (S1 level) Target: $246.13 (R1 level)

Technical Analysis: Based on the technical indicators, DHR is showing mixed signals. The RSI(14) at 63.44 indicates the stock is approaching overbought territory but not yet overextended. The MACD at 2.53 suggests positive momentum. The stock is currently trading below its 200-day SMA of $253.30, indicating a longer-term bearish trend, but above its 20-day SMA of $237.15, showing short-term strength.

News Analysis: Recent news indicates several significant developments:

  • DHR will report Q4 earnings on January 30, 2025
  • Bank of America maintains a "Buy" rating with a $290 price target, implying an 18% upside potential
  • Wall Street analysts are overwhelmingly bullish on DHR, with most assigning either "Strong Buy" or "Buy" ratings

Price Prediction for Next Week: Based on Fibonacci levels:

  • Resistance levels: R1: $246.13, R2: $249.78, R3: $255.70
  • Support levels: S1: $234.29, S2: $230.64, S3: $224.73
  • Pivot: $240.21

Given the upcoming earnings report and current technical setup, DHR is likely to trade between $240-$250 next week. The stock should find strong support at $234.29 and face resistance at $246.13.

Trading Recommendation: BUY Rationale:

  1. Positive momentum indicators
  2. Strong analyst support with consensus bullish ratings
  3. Upcoming earnings catalyst
  4. Trading above short-term moving averages

Entry point: Current market price with stop loss at $234.29 (S1 level) Target: $246.13 (R1 level)

DHR Similar Chart Price Prediction

The price of DHR is predicted to go up -11.74%, based on the high correlation periods with NXE. The similarity of these two price pattern on the periods is 96.85%.

stocks logo

DHR

stocks logo

NXE

Down: -11.74%Similarity: 96.85%

DHR Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

DHR Price Forecast($)

Potential Return(%)

2025

234.840

0.000

2026

234.840

0.000

2027

310.000

32.000

2028

310.000

32.000

2029

320.000

34.340

2030

350.000

46.940

What is DHR stock price prediction 2025 ?

Danaher Corporation (DHR) is currently trading at $234.84. Analysts' consensus price target for 2025 is approximately $291.30, reflecting a potential upside of 24%. This projection is supported by strong fundamentals in life sciences and diagnostics, despite recent challenges in margins and growth.

What is DHR stock price prediction 2026 ?

Danaher Corporation (DHR) is currently trading at $234.84. Analysts project a 2026 price target range of $265 to $315, with an average of $291. This forecast reflects expectations of moderate earnings growth and recovery in its core segments, supported by strong fundamentals and market leadership in life sciences and diagnostics.

What is DHR stock price prediction 2027 ?

DHR's stock price in 2027 is projected to reach approximately $310, driven by its strong position in life sciences and diagnostics, coupled with consistent revenue growth and operational efficiency. Analysts' consensus price targets for the next 12 months already suggest a premium of over 25% from current levels, indicating long-term confidence in the stock. However, potential risks include market volatility and challenges in maintaining margins amidst competitive pressures.

What is DHR stock price prediction 2028 ?

DHR's stock price in 2028 is projected to reach approximately $310, driven by its strong position in life sciences and diagnostics, coupled with consistent revenue growth and operational efficiency. Analysts' consensus price targets and historical performance suggest a steady upward trajectory, despite recent challenges. However, macroeconomic factors and sector-specific risks could influence this estimate.

What is DHR stock price prediction 2029 ?

DHR stock price prediction for 2029 is estimated to reach $320. This projection is based on consistent revenue growth in life sciences and diagnostics, coupled with strong analyst sentiment and a historical average annual growth rate of 6-8%. However, potential risks include macroeconomic headwinds and sector-specific challenges.

What is DHR stock price prediction 2030 ?

DHR stock is projected to reach approximately $350 by 2030, driven by its strong position in life sciences and diagnostics, consistent revenue growth, and operational efficiency. Analysts expect Danaher to maintain a low double-digit EPS growth trajectory, supported by its robust business model and strategic acquisitions. However, macroeconomic factors and competitive pressures could influence this forecast.

DHR Revenue Forecast

DHR EPS Forecast

DHR FAQs

What is bull’s view on DHR?

DHR stock has a bullish outlook with a price target of $290 by B of A Securities, reflecting a 26.89% upside. This optimism is driven by expectations of 6% core sales growth and 29% operating margin in 2025, alongside potential multiple expansion. Wolfe Research also supports this view, projecting upward revisions to consensus estimates and a price target of $285.

What is bear's view on DHR?

DHR stock currently trades at $234.84, reflecting a +2.19% gain on January 3, 2025. Bearish sentiment arises from its underperformance compared to peers, trading below its 50-day and 200-day moving averages, and a weak Q4 outlook with projected core sales declines. Analysts' average price target of $293.29 suggests potential upside, but recent margin contractions and a 19.1% drop from its 52-week high signal caution.

What is DHR revenue forecast for next quarter？

The market consensus for DHR's revenue in the upcoming quarter is projected to be approximately $5.951B USD.

What is DHR eps forecast for next quarter？

The market consensus for DHR's eps in the upcoming quarter is projected to be approximately $2.025 USD.

DHR VS S&P500

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Danaher's shift to healthcare markets has created a less cyclical business in attractive markets with high barriers to entry and impressive recurring consumables revenue streams.

Danaher has plenty of opportunities to consolidate and improve performance in its targeted life science and diagnostic end markets.

Ask Intellectia about DHR

DHR Analyst's Forecast

Patrick Donnelly

Citigroup

Strong Buy

Price Target

$305 → $285

Upside

+19.65%

Citi analyst Patrick Donnelly lowered the firm's price target on Danaher to $285 from $305 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and diagnostics names in January, Citi expects key themes to include the cadence and magnitude of the expected recoveries in areas such as China and bioprocessing, the rollout of the China stimulus program, trends within the instrumentation replacement cycle, general biopharma health and its possible impact on clinical trial demand, and the possible effects of the new administration. The firm adjusted numbers for Danaher to reflect currency headwinds.
Doug Schenkel

Wolfe Research

Hold → Buy

Price Target

$285

Upside

+15.32%

Dan Brennan

TD Cowen

Strong Buy

Price Target

$310 → $315

Upside

+22.75%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free